Chuang CH - Search Results

1

Clinical outcome of bevacizumab or ramucirumab combined with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors as the first line therapy in susceptible EGFR-mutated advanced non-small-cell lung.

Kuo CY, Tsai MJ, Hung JY, Lee MH, Wu KL, Tsai YC, Chuang CH, Huang CW, Chen CL, Yang CJ, Chong IW. Kuo CY, et al. Among authors: chuang ch. Kaohsiung J Med Sci. 2024 May;40(5):467-476. doi: 10.1002/kjm2.12822. Epub 2024 Mar 25. Kaohsiung J Med Sci. 2024. PMID: 38523603 Free article.

2

Regression of a metastatic lung mass after receiving whole brain irradiation: Can the abscopal effect cross the blood-brain barrier?

Chuang CH, Hsu JF, Shen YT, Yang CJ. Chuang CH, et al. Asia Pac J Clin Oncol. 2018 Oct;14(5):e548-e550. doi: 10.1111/ajco.13051. Epub 2018 Jul 8. Asia Pac J Clin Oncol. 2018. PMID: 29984499

3

Targeting Pin1 for Modulation of Cell Motility and Cancer Therapy.

Chuang HH, Zhen YY, Tsai YC, Chuang CH, Huang MS, Hsiao M, Yang CJ. Chuang HH, et al. Among authors: chuang ch. Biomedicines. 2021 Mar 31;9(4):359. doi: 10.3390/biomedicines9040359. Biomedicines. 2021. PMID: 33807199 Free PMC article. Review.

4

Systematic Review and Network Meta-Analysis of Anaplastic Lymphoma Kinase (ALK) Inhibitors for Treatment-Naïve ALK-Positive Lung Cancer.

Chuang CH, Chen HL, Chang HM, Tsai YC, Wu KL, Chen IH, Chen KC, Lee JY, Chang YC, Chen CL, Tu YK, Hung JY, Yang CJ, Chong IW. Chuang CH, et al. Cancers (Basel). 2021 Apr 19;13(8):1966. doi: 10.3390/cancers13081966. Cancers (Basel). 2021. PMID: 33921762 Free PMC article. Review.

5

Reply.

Liu PK, Chang YC, Chuang CH, Tsai MJ. Liu PK, et al. Among authors: chuang ch. Retina. 2021 Sep 1;41(9):e61-e64. doi: 10.1097/IAE.0000000000003198. Retina. 2021. PMID: 33958530 No abstract available.

6

Emergent bronchoscopic cryotherapy may safely cease invasive lung cancer induced massive endobronchial hemorrhaging in patients with high oxygen supply.

Shen FC, Chuang CH, Tsai YM, Yang CJ. Shen FC, et al. Among authors: chuang ch. Kaohsiung J Med Sci. 2021 Sep;37(9):833-834. doi: 10.1002/kjm2.12407. Epub 2021 Jun 9. Kaohsiung J Med Sci. 2021. PMID: 34105889 Free article. No abstract available.

7

First-Line Anaplastic Lymphoma Kinase (ALK) Inhibitors for ALK-Positive Lung Cancer in Asian Populations: Systematic Review and Network Meta-Analysis.

Wu KL, Chen HL, Tsai YM, Lee TH, Chang HM, Tsai YC, Chuang CH, Chang YC, Tu YK, Yang CJ, Hung JY, Chong IW. Wu KL, et al. Among authors: chuang ch. J Clin Med. 2021 Sep 25;10(19):4376. doi: 10.3390/jcm10194376. J Clin Med. 2021. PMID: 34640394 Free PMC article. Review.

8

Salvage Therapy for Relapsed Malignant Pleural Mesothelioma: A Systematic Review and Network Meta-Analysis.

Tsai YC, Chen HL, Lee TH, Chang HM, Wu KL, Chuang CH, Chang YC, Tu YK, Hung JY, Yang CJ, Chong IW. Tsai YC, et al. Among authors: chuang ch. Cancers (Basel). 2021 Dec 30;14(1):182. doi: 10.3390/cancers14010182. Cancers (Basel). 2021. PMID: 35008346 Free PMC article. Review.

9

Cysteinyl Leukotriene Pathway and Cancer.

Tsai MJ, Chang WA, Chuang CH, Wu KL, Cheng CH, Sheu CC, Hsu YL, Hung JY. Tsai MJ, et al. Among authors: chuang ch. Int J Mol Sci. 2021 Dec 23;23(1):120. doi: 10.3390/ijms23010120. Int J Mol Sci. 2021. PMID: 35008546 Free PMC article. Review.

10

FAK in Cancer: From Mechanisms to Therapeutic Strategies.

Chuang HH, Zhen YY, Tsai YC, Chuang CH, Hsiao M, Huang MS, Yang CJ. Chuang HH, et al. Among authors: chuang ch. Int J Mol Sci. 2022 Feb 2;23(3):1726. doi: 10.3390/ijms23031726. Int J Mol Sci. 2022. PMID: 35163650 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

662 results

Search Page